COVID-19 Impact on Global Antibody Drugs Market Insights, Forecast to 2026
Antibody Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibody Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antibody Drugs market is segmented into
The Antibody Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antibody Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antibody Drugs Market Share Analysis
Antibody Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antibody Drugs business, the date to enter into the Antibody Drugs market, Antibody Drugs product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Antibody Drugs market is segmented into
- Monoclonal Antibodies
- Antibody-Drug Conjugates
- Polyclonal Antibodies
- Central Nervous System (CNS) Disorders
- Cancers
- Autoimmune Disorders
- Cardiovascular Diseases
The Antibody Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antibody Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antibody Drugs Market Share Analysis
Antibody Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antibody Drugs business, the date to enter into the Antibody Drugs market, Antibody Drugs product introduction, recent developments, etc.
The major vendors covered:
- Novartis
- Amgen
- Bristol-Myers Squibb
- F. Hoffmann-La Roche
- Johnson & Johnson
- AbbVie
- Eli Lilly
- Pfizer
- Bayer
- GlaxoSmithKline
- Sanofi
1 STUDY COVERAGE
1.1 Antibody Drugs Product Introduction
1.2 Market Segments
1.3 Key Antibody Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antibody Drugs Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Antibody-Drug Conjugates
1.4.4 Polyclonal Antibodies
1.5 Market by Application
1.5.1 Global Antibody Drugs Market Size Growth Rate by Application
1.5.2 Central Nervous System (CNS) Disorders
1.5.3 Cancers
1.5.4 Autoimmune Disorders
1.5.5 Cardiovascular Diseases
1.6 Coronavirus Disease 2019 (Covid-19): Antibody Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Antibody Drugs Industry
1.6.1.1 Antibody Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Antibody Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Antibody Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Antibody Drugs Market Size Estimates and Forecasts
2.1.1 Global Antibody Drugs Revenue 2015-2026
2.1.2 Global Antibody Drugs Sales 2015-2026
2.2 Antibody Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Antibody Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antibody Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ANTIBODY DRUGS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Antibody Drugs Sales by Manufacturers
3.1.1 Antibody Drugs Sales by Manufacturers (2015-2020)
3.1.2 Antibody Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Antibody Drugs Revenue by Manufacturers
3.2.1 Antibody Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Antibody Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antibody Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antibody Drugs Revenue in 2019
3.2.5 Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antibody Drugs Price by Manufacturers
3.4 Antibody Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antibody Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibody Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antibody Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Antibody Drugs Market Size by Type (2015-2020)
4.1.1 Global Antibody Drugs Sales by Type (2015-2020)
4.1.2 Global Antibody Drugs Revenue by Type (2015-2020)
4.1.3 Antibody Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antibody Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Antibody Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Antibody Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Antibody Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antibody Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Antibody Drugs Market Size by Application (2015-2020)
5.1.1 Global Antibody Drugs Sales by Application (2015-2020)
5.1.2 Global Antibody Drugs Revenue by Application (2015-2020)
5.1.3 Antibody Drugs Price by Application (2015-2020)
5.2 Antibody Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Antibody Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Antibody Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibody Drugs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Antibody Drugs by Country
6.1.1 North America Antibody Drugs Sales by Country
6.1.2 North America Antibody Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antibody Drugs Market Facts & Figures by Type
6.3 North America Antibody Drugs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Antibody Drugs by Country
7.1.1 Europe Antibody Drugs Sales by Country
7.1.2 Europe Antibody Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibody Drugs Market Facts & Figures by Type
7.3 Europe Antibody Drugs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Antibody Drugs by Region
8.1.1 Asia Pacific Antibody Drugs Sales by Region
8.1.2 Asia Pacific Antibody Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antibody Drugs Market Facts & Figures by Type
8.3 Asia Pacific Antibody Drugs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Antibody Drugs by Country
9.1.1 Latin America Antibody Drugs Sales by Country
9.1.2 Latin America Antibody Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antibody Drugs Market Facts & Figures by Type
9.3 Central & South America Antibody Drugs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Antibody Drugs by Country
10.1.1 Middle East and Africa Antibody Drugs Sales by Country
10.1.2 Middle East and Africa Antibody Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antibody Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Antibody Drugs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Antibody Drugs Products Offered
11.1.5 Novartis Recent Development
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description, Business Overview and Total Revenue
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Antibody Drugs Products Offered
11.2.5 Amgen Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.3.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bristol-Myers Squibb Antibody Drugs Products Offered
11.3.5 Bristol-Myers Squibb Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Corporation Information
11.4.2 F. Hoffmann-La Roche Description, Business Overview and Total Revenue
11.4.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Antibody Drugs Products Offered
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Johnson & Johnson Antibody Drugs Products Offered
11.5.5 Johnson & Johnson Recent Development
11.6 AbbVie
11.6.1 AbbVie Corporation Information
11.6.2 AbbVie Description, Business Overview and Total Revenue
11.6.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AbbVie Antibody Drugs Products Offered
11.6.5 AbbVie Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Corporation Information
11.7.2 Eli Lilly Description, Business Overview and Total Revenue
11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly Antibody Drugs Products Offered
11.7.5 Eli Lilly Recent Development
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description, Business Overview and Total Revenue
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Antibody Drugs Products Offered
11.8.5 Pfizer Recent Development
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Description, Business Overview and Total Revenue
11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bayer Antibody Drugs Products Offered
11.9.5 Bayer Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Corporation Information
11.10.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.10.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.10.4 GlaxoSmithKline Antibody Drugs Products Offered
11.10.5 GlaxoSmithKline Recent Development
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Antibody Drugs Products Offered
11.1.5 Novartis Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Antibody Drugs Market Estimates and Projections by Region
12.1.1 Global Antibody Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Antibody Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Antibody Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Antibody Drugs Sales Forecast (2021-2026)
12.2.2 North America: Antibody Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Antibody Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Antibody Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Antibody Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Antibody Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Antibody Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antibody Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antibody Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antibody Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antibody Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Antibody Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Antibody Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Antibody Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Antibody Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antibody Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antibody Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antibody Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antibody Drugs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antibody Drugs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Antibody Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Antibody Drugs Product Introduction
1.2 Market Segments
1.3 Key Antibody Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antibody Drugs Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Antibody-Drug Conjugates
1.4.4 Polyclonal Antibodies
1.5 Market by Application
1.5.1 Global Antibody Drugs Market Size Growth Rate by Application
1.5.2 Central Nervous System (CNS) Disorders
1.5.3 Cancers
1.5.4 Autoimmune Disorders
1.5.5 Cardiovascular Diseases
1.6 Coronavirus Disease 2019 (Covid-19): Antibody Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Antibody Drugs Industry
1.6.1.1 Antibody Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Antibody Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Antibody Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Antibody Drugs Market Size Estimates and Forecasts
2.1.1 Global Antibody Drugs Revenue 2015-2026
2.1.2 Global Antibody Drugs Sales 2015-2026
2.2 Antibody Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Antibody Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antibody Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ANTIBODY DRUGS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Antibody Drugs Sales by Manufacturers
3.1.1 Antibody Drugs Sales by Manufacturers (2015-2020)
3.1.2 Antibody Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Antibody Drugs Revenue by Manufacturers
3.2.1 Antibody Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Antibody Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antibody Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antibody Drugs Revenue in 2019
3.2.5 Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antibody Drugs Price by Manufacturers
3.4 Antibody Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antibody Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibody Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antibody Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Antibody Drugs Market Size by Type (2015-2020)
4.1.1 Global Antibody Drugs Sales by Type (2015-2020)
4.1.2 Global Antibody Drugs Revenue by Type (2015-2020)
4.1.3 Antibody Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antibody Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Antibody Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Antibody Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Antibody Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antibody Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Antibody Drugs Market Size by Application (2015-2020)
5.1.1 Global Antibody Drugs Sales by Application (2015-2020)
5.1.2 Global Antibody Drugs Revenue by Application (2015-2020)
5.1.3 Antibody Drugs Price by Application (2015-2020)
5.2 Antibody Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Antibody Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Antibody Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibody Drugs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Antibody Drugs by Country
6.1.1 North America Antibody Drugs Sales by Country
6.1.2 North America Antibody Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antibody Drugs Market Facts & Figures by Type
6.3 North America Antibody Drugs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Antibody Drugs by Country
7.1.1 Europe Antibody Drugs Sales by Country
7.1.2 Europe Antibody Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibody Drugs Market Facts & Figures by Type
7.3 Europe Antibody Drugs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Antibody Drugs by Region
8.1.1 Asia Pacific Antibody Drugs Sales by Region
8.1.2 Asia Pacific Antibody Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antibody Drugs Market Facts & Figures by Type
8.3 Asia Pacific Antibody Drugs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Antibody Drugs by Country
9.1.1 Latin America Antibody Drugs Sales by Country
9.1.2 Latin America Antibody Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antibody Drugs Market Facts & Figures by Type
9.3 Central & South America Antibody Drugs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Antibody Drugs by Country
10.1.1 Middle East and Africa Antibody Drugs Sales by Country
10.1.2 Middle East and Africa Antibody Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antibody Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Antibody Drugs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Antibody Drugs Products Offered
11.1.5 Novartis Recent Development
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description, Business Overview and Total Revenue
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Antibody Drugs Products Offered
11.2.5 Amgen Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.3.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bristol-Myers Squibb Antibody Drugs Products Offered
11.3.5 Bristol-Myers Squibb Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Corporation Information
11.4.2 F. Hoffmann-La Roche Description, Business Overview and Total Revenue
11.4.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Antibody Drugs Products Offered
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Johnson & Johnson Antibody Drugs Products Offered
11.5.5 Johnson & Johnson Recent Development
11.6 AbbVie
11.6.1 AbbVie Corporation Information
11.6.2 AbbVie Description, Business Overview and Total Revenue
11.6.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AbbVie Antibody Drugs Products Offered
11.6.5 AbbVie Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Corporation Information
11.7.2 Eli Lilly Description, Business Overview and Total Revenue
11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly Antibody Drugs Products Offered
11.7.5 Eli Lilly Recent Development
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description, Business Overview and Total Revenue
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Antibody Drugs Products Offered
11.8.5 Pfizer Recent Development
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Description, Business Overview and Total Revenue
11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bayer Antibody Drugs Products Offered
11.9.5 Bayer Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Corporation Information
11.10.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.10.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.10.4 GlaxoSmithKline Antibody Drugs Products Offered
11.10.5 GlaxoSmithKline Recent Development
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Antibody Drugs Products Offered
11.1.5 Novartis Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Antibody Drugs Market Estimates and Projections by Region
12.1.1 Global Antibody Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Antibody Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Antibody Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Antibody Drugs Sales Forecast (2021-2026)
12.2.2 North America: Antibody Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Antibody Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Antibody Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Antibody Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Antibody Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Antibody Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antibody Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antibody Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antibody Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antibody Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Antibody Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Antibody Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Antibody Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Antibody Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antibody Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antibody Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antibody Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antibody Drugs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antibody Drugs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Antibody Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Antibody Drugs Market Segments
Table 2. Ranking of Global Top Antibody Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antibody Drugs Market Size Growth Rate by Type 2020-2026 (mg) & (US$ Million)
Table 4. Major Manufacturers of Monoclonal Antibodies
Table 5. Major Manufacturers of Antibody-Drug Conjugates
Table 6. Major Manufacturers of Polyclonal Antibodies
Table 7. COVID-19 Impact Global Market: (Four Antibody Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Antibody Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Antibody Drugs Players to Combat Covid-19 Impact
Table 12. Global Antibody Drugs Market Size Growth Rate by Application 2020-2026 (mg)
Table 13. Global Antibody Drugs Market Size by Region (mg) & (US$ Million): 2020 VS 2026
Table 14. Global Antibody Drugs Sales by Regions 2015-2020 (mg)
Table 15. Global Antibody Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global Antibody Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Antibody Drugs Sales by Manufacturers (2015-2020) (mg)
Table 18. Global Antibody Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Global Antibody Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Antibody Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drugs as of 2019)
Table 21. Antibody Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Antibody Drugs Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Antibody Drugs Price (2015-2020) (USD/mg)
Table 24. Antibody Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Antibody Drugs Product Type
Table 26. Date of International Manufacturers Enter into Antibody Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Antibody Drugs Sales by Type (2015-2020) (mg)
Table 29. Global Antibody Drugs Sales Share by Type (2015-2020)
Table 30. Global Antibody Drugs Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Antibody Drugs Revenue Share by Type (2015-2020)
Table 32. Antibody Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/mg)
Table 33. Global Antibody Drugs Sales by Application (2015-2020) (mg)
Table 34. Global Antibody Drugs Sales Share by Application (2015-2020)
Table 35. North America Antibody Drugs Sales by Country (2015-2020) (mg)
Table 36. North America Antibody Drugs Sales Market Share by Country (2015-2020)
Table 37. North America Antibody Drugs Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Antibody Drugs Revenue Market Share by Country (2015-2020)
Table 39. North America Antibody Drugs Sales by Type (2015-2020) (mg)
Table 40. North America Antibody Drugs Sales Market Share by Type (2015-2020)
Table 41. North America Antibody Drugs Sales by Application (2015-2020) (mg)
Table 42. North America Antibody Drugs Sales Market Share by Application (2015-2020)
Table 43. Europe Antibody Drugs Sales by Country (2015-2020) (mg)
Table 44. Europe Antibody Drugs Sales Market Share by Country (2015-2020)
Table 45. Europe Antibody Drugs Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Antibody Drugs Revenue Market Share by Country (2015-2020)
Table 47. Europe Antibody Drugs Sales by Type (2015-2020) (mg)
Table 48. Europe Antibody Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Antibody Drugs Sales by Application (2015-2020) (mg)
Table 50. Europe Antibody Drugs Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Antibody Drugs Sales by Region (2015-2020) (mg)
Table 52. Asia Pacific Antibody Drugs Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Antibody Drugs Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Antibody Drugs Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Antibody Drugs Sales by Type (2015-2020) (mg)
Table 56. Asia Pacific Antibody Drugs Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Antibody Drugs Sales by Application (2015-2020) (mg)
Table 58. Asia Pacific Antibody Drugs Sales Market Share by Application (2015-2020)
Table 59. Latin America Antibody Drugs Sales by Country (2015-2020) (mg)
Table 60. Latin America Antibody Drugs Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Antibody Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Antibody Drugs Revenue Market Share by Country (2015-2020)
Table 63. Latin America Antibody Drugs Sales by Type (2015-2020) (mg)
Table 64. Latin America Antibody Drugs Sales Market Share by Type (2015-2020)
Table 65. Latin America Antibody Drugs Sales by Application (2015-2020) (mg)
Table 66. Latin America Antibody Drugs Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Antibody Drugs Sales by Country (2015-2020) (mg)
Table 68. Middle East and Africa Antibody Drugs Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Antibody Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Antibody Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Antibody Drugs Sales by Type (2015-2020) (mg)
Table 72. Middle East and Africa Antibody Drugs Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Antibody Drugs Sales by Application (2015-2020) (mg)
Table 74. Middle East and Africa Antibody Drugs Sales Market Share by Application (2015-2020)
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Major Businesses
Table 77. Novartis Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 78. Novartis Product
Table 79. Novartis Recent Development
Table 80. Amgen Corporation Information
Table 81. Amgen Description and Major Businesses
Table 82. Amgen Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 83. Amgen Product
Table 84. Amgen Recent Development
Table 85. Bristol-Myers Squibb Corporation Information
Table 86. Bristol-Myers Squibb Description and Major Businesses
Table 87. Bristol-Myers Squibb Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 88. Bristol-Myers Squibb Product
Table 89. Bristol-Myers Squibb Recent Development
Table 90. F. Hoffmann-La Roche Corporation Information
Table 91. F. Hoffmann-La Roche Description and Major Businesses
Table 92. F. Hoffmann-La Roche Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 93. F. Hoffmann-La Roche Product
Table 94. F. Hoffmann-La Roche Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Major Businesses
Table 97. Johnson & Johnson Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Product
Table 99. Johnson & Johnson Recent Development
Table 100. AbbVie Corporation Information
Table 101. AbbVie Description and Major Businesses
Table 102. AbbVie Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 103. AbbVie Product
Table 104. AbbVie Recent Development
Table 105. Eli Lilly Corporation Information
Table 106. Eli Lilly Description and Major Businesses
Table 107. Eli Lilly Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 108. Eli Lilly Product
Table 109. Eli Lilly Recent Development
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Major Businesses
Table 112. Pfizer Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 113. Pfizer Product
Table 114. Pfizer Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Major Businesses
Table 117. Bayer Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 118. Bayer Product
Table 119. Bayer Recent Development
Table 120. GlaxoSmithKline Corporation Information
Table 121. GlaxoSmithKline Description and Major Businesses
Table 122. GlaxoSmithKline Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 123. GlaxoSmithKline Product
Table 124. GlaxoSmithKline Recent Development
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Major Businesses
Table 127. Sanofi Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 128. Sanofi Product
Table 129. Sanofi Recent Development
Table 130. Global Antibody Drugs Sales Forecast by Regions (2021-2026) (mg)
Table 131. Global Antibody Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 132. Global Antibody Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 133. Global Antibody Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 134. North America: Antibody Drugs Sales Forecast by Country (2021-2026) (mg)
Table 135. North America: Antibody Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Europe: Antibody Drugs Sales Forecast by Country (2021-2026) (mg)
Table 137. Europe: Antibody Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Asia Pacific: Antibody Drugs Sales Forecast by Region (2021-2026) (mg)
Table 139. Asia Pacific: Antibody Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 140. Latin America: Antibody Drugs Sales Forecast by Country (2021-2026) (mg)
Table 141. Latin America: Antibody Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Middle East and Africa: Antibody Drugs Sales Forecast by Country (2021-2026) (mg)
Table 143. Middle East and Africa: Antibody Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 145. Key Challenges
Table 146. Market Risks
Table 147. Main Points Interviewed from Key Antibody Drugs Players
Table 148. Antibody Drugs Customers List
Table 149. Antibody Drugs Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 1. Antibody Drugs Market Segments
Table 2. Ranking of Global Top Antibody Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antibody Drugs Market Size Growth Rate by Type 2020-2026 (mg) & (US$ Million)
Table 4. Major Manufacturers of Monoclonal Antibodies
Table 5. Major Manufacturers of Antibody-Drug Conjugates
Table 6. Major Manufacturers of Polyclonal Antibodies
Table 7. COVID-19 Impact Global Market: (Four Antibody Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Antibody Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Antibody Drugs Players to Combat Covid-19 Impact
Table 12. Global Antibody Drugs Market Size Growth Rate by Application 2020-2026 (mg)
Table 13. Global Antibody Drugs Market Size by Region (mg) & (US$ Million): 2020 VS 2026
Table 14. Global Antibody Drugs Sales by Regions 2015-2020 (mg)
Table 15. Global Antibody Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global Antibody Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Antibody Drugs Sales by Manufacturers (2015-2020) (mg)
Table 18. Global Antibody Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Global Antibody Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Antibody Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drugs as of 2019)
Table 21. Antibody Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Antibody Drugs Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Antibody Drugs Price (2015-2020) (USD/mg)
Table 24. Antibody Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Antibody Drugs Product Type
Table 26. Date of International Manufacturers Enter into Antibody Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Antibody Drugs Sales by Type (2015-2020) (mg)
Table 29. Global Antibody Drugs Sales Share by Type (2015-2020)
Table 30. Global Antibody Drugs Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Antibody Drugs Revenue Share by Type (2015-2020)
Table 32. Antibody Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/mg)
Table 33. Global Antibody Drugs Sales by Application (2015-2020) (mg)
Table 34. Global Antibody Drugs Sales Share by Application (2015-2020)
Table 35. North America Antibody Drugs Sales by Country (2015-2020) (mg)
Table 36. North America Antibody Drugs Sales Market Share by Country (2015-2020)
Table 37. North America Antibody Drugs Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Antibody Drugs Revenue Market Share by Country (2015-2020)
Table 39. North America Antibody Drugs Sales by Type (2015-2020) (mg)
Table 40. North America Antibody Drugs Sales Market Share by Type (2015-2020)
Table 41. North America Antibody Drugs Sales by Application (2015-2020) (mg)
Table 42. North America Antibody Drugs Sales Market Share by Application (2015-2020)
Table 43. Europe Antibody Drugs Sales by Country (2015-2020) (mg)
Table 44. Europe Antibody Drugs Sales Market Share by Country (2015-2020)
Table 45. Europe Antibody Drugs Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Antibody Drugs Revenue Market Share by Country (2015-2020)
Table 47. Europe Antibody Drugs Sales by Type (2015-2020) (mg)
Table 48. Europe Antibody Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Antibody Drugs Sales by Application (2015-2020) (mg)
Table 50. Europe Antibody Drugs Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Antibody Drugs Sales by Region (2015-2020) (mg)
Table 52. Asia Pacific Antibody Drugs Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Antibody Drugs Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Antibody Drugs Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Antibody Drugs Sales by Type (2015-2020) (mg)
Table 56. Asia Pacific Antibody Drugs Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Antibody Drugs Sales by Application (2015-2020) (mg)
Table 58. Asia Pacific Antibody Drugs Sales Market Share by Application (2015-2020)
Table 59. Latin America Antibody Drugs Sales by Country (2015-2020) (mg)
Table 60. Latin America Antibody Drugs Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Antibody Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Antibody Drugs Revenue Market Share by Country (2015-2020)
Table 63. Latin America Antibody Drugs Sales by Type (2015-2020) (mg)
Table 64. Latin America Antibody Drugs Sales Market Share by Type (2015-2020)
Table 65. Latin America Antibody Drugs Sales by Application (2015-2020) (mg)
Table 66. Latin America Antibody Drugs Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Antibody Drugs Sales by Country (2015-2020) (mg)
Table 68. Middle East and Africa Antibody Drugs Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Antibody Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Antibody Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Antibody Drugs Sales by Type (2015-2020) (mg)
Table 72. Middle East and Africa Antibody Drugs Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Antibody Drugs Sales by Application (2015-2020) (mg)
Table 74. Middle East and Africa Antibody Drugs Sales Market Share by Application (2015-2020)
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Major Businesses
Table 77. Novartis Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 78. Novartis Product
Table 79. Novartis Recent Development
Table 80. Amgen Corporation Information
Table 81. Amgen Description and Major Businesses
Table 82. Amgen Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 83. Amgen Product
Table 84. Amgen Recent Development
Table 85. Bristol-Myers Squibb Corporation Information
Table 86. Bristol-Myers Squibb Description and Major Businesses
Table 87. Bristol-Myers Squibb Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 88. Bristol-Myers Squibb Product
Table 89. Bristol-Myers Squibb Recent Development
Table 90. F. Hoffmann-La Roche Corporation Information
Table 91. F. Hoffmann-La Roche Description and Major Businesses
Table 92. F. Hoffmann-La Roche Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 93. F. Hoffmann-La Roche Product
Table 94. F. Hoffmann-La Roche Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Major Businesses
Table 97. Johnson & Johnson Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Product
Table 99. Johnson & Johnson Recent Development
Table 100. AbbVie Corporation Information
Table 101. AbbVie Description and Major Businesses
Table 102. AbbVie Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 103. AbbVie Product
Table 104. AbbVie Recent Development
Table 105. Eli Lilly Corporation Information
Table 106. Eli Lilly Description and Major Businesses
Table 107. Eli Lilly Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 108. Eli Lilly Product
Table 109. Eli Lilly Recent Development
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Major Businesses
Table 112. Pfizer Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 113. Pfizer Product
Table 114. Pfizer Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Major Businesses
Table 117. Bayer Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 118. Bayer Product
Table 119. Bayer Recent Development
Table 120. GlaxoSmithKline Corporation Information
Table 121. GlaxoSmithKline Description and Major Businesses
Table 122. GlaxoSmithKline Antibody Drugs Production (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 123. GlaxoSmithKline Product
Table 124. GlaxoSmithKline Recent Development
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Major Businesses
Table 127. Sanofi Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 128. Sanofi Product
Table 129. Sanofi Recent Development
Table 130. Global Antibody Drugs Sales Forecast by Regions (2021-2026) (mg)
Table 131. Global Antibody Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 132. Global Antibody Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 133. Global Antibody Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 134. North America: Antibody Drugs Sales Forecast by Country (2021-2026) (mg)
Table 135. North America: Antibody Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Europe: Antibody Drugs Sales Forecast by Country (2021-2026) (mg)
Table 137. Europe: Antibody Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Asia Pacific: Antibody Drugs Sales Forecast by Region (2021-2026) (mg)
Table 139. Asia Pacific: Antibody Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 140. Latin America: Antibody Drugs Sales Forecast by Country (2021-2026) (mg)
Table 141. Latin America: Antibody Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Middle East and Africa: Antibody Drugs Sales Forecast by Country (2021-2026) (mg)
Table 143. Middle East and Africa: Antibody Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 145. Key Challenges
Table 146. Market Risks
Table 147. Main Points Interviewed from Key Antibody Drugs Players
Table 148. Antibody Drugs Customers List
Table 149. Antibody Drugs Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Antibody Drugs Product Picture
Figure 2. Global Antibody Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Antibody-Drug Conjugates Product Picture
Figure 5. Polyclonal Antibodies Product Picture
Figure 6. Global Antibody Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Central Nervous System (CNS) Disorders
Figure 8. Cancers
Figure 9. Autoimmune Disorders
Figure 10. Cardiovascular Diseases
Figure 11. Antibody Drugs Report Years Considered
Figure 12. Global Antibody Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Antibody Drugs Sales 2015-2026 (mg)
Figure 14. Global Antibody Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Antibody Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Antibody Drugs Sales Market Share by Region in 2019
Figure 17. Global Antibody Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Antibody Drugs Revenue Market Share by Region in 2019
Figure 19. Global Antibody Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Antibody Drugs Revenue in 2019
Figure 21. Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Antibody Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Antibody Drugs Sales Market Share by Type in 2019
Figure 24. Global Antibody Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Antibody Drugs Revenue Market Share by Type in 2019
Figure 26. Global Antibody Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Antibody Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Antibody Drugs Sales Market Share by Application in 2019
Figure 29. Global Antibody Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Antibody Drugs Revenue Market Share by Application in 2019
Figure 31. North America Antibody Drugs Sales Growth Rate 2015-2020 (mg)
Figure 32. North America Antibody Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Antibody Drugs Sales Market Share by Country in 2019
Figure 34. North America Antibody Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 36. U.S. Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 38. Canada Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Antibody Drugs Market Share by Type in 2019
Figure 40. North America Antibody Drugs Market Share by Application in 2019
Figure 41. Europe Antibody Drugs Sales Growth Rate 2015-2020 (mg)
Figure 42. Europe Antibody Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Antibody Drugs Sales Market Share by Country in 2019
Figure 44. Europe Antibody Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 46. Germany Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 48. France Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 50. U.K. Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 52. Italy Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 54. Russia Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Antibody Drugs Market Share by Type in 2019
Figure 56. Europe Antibody Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Antibody Drugs Sales Growth Rate 2015-2020 (mg)
Figure 58. Asia Pacific Antibody Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Antibody Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Antibody Drugs Revenue Market Share by Region in 2019
Figure 61. China Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 62. China Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 64. Japan Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 66. South Korea Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 68. India Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 70. Australia Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 72. Taiwan Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 74. Indonesia Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 76. Thailand Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 78. Malaysia Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 80. Philippines Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 82. Vietnam Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Antibody Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Antibody Drugs Market Share by Application in 2019
Figure 85. Latin America Antibody Drugs Sales Growth Rate 2015-2020 (mg)
Figure 86. Latin America Antibody Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Antibody Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Antibody Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 90. Mexico Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 92. Brazil Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 94. Argentina Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Antibody Drugs Market Share by Type in 2019
Figure 96. Latin America Antibody Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Antibody Drugs Sales Growth Rate 2015-2020 (mg)
Figure 98. Middle East and Africa Antibody Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Antibody Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Antibody Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 102. Turkey Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 104. Saudi Arabia Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 106. U.A.E Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Antibody Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Antibody Drugs Market Share by Application in 2019
Figure 109. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. North America Antibody Drugs Sales Growth Rate Forecast (2021-2026) (mg)
Figure 121. North America Antibody Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Europe Antibody Drugs Sales Growth Rate Forecast (2021-2026) (mg)
Figure 123. Europe Antibody Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Asia Pacific Antibody Drugs Sales Growth Rate Forecast (2021-2026) (mg)
Figure 125. Asia Pacific Antibody Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Latin America Antibody Drugs Sales Growth Rate Forecast (2021-2026) (mg)
Figure 127. Latin America Antibody Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Middle East and Africa Antibody Drugs Sales Growth Rate Forecast (2021-2026) (mg)
Figure 129. Middle East and Africa Antibody Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Porter's Five Forces Analysis
Figure 131. Channels of Distribution
Figure 132. Distributors Profiles
Figure 133. Bottom-up and Top-down Approaches for This Report
Figure 134. Data Triangulation
Figure 135. Key Executives Interviewed
Figure 1. Antibody Drugs Product Picture
Figure 2. Global Antibody Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Antibody-Drug Conjugates Product Picture
Figure 5. Polyclonal Antibodies Product Picture
Figure 6. Global Antibody Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Central Nervous System (CNS) Disorders
Figure 8. Cancers
Figure 9. Autoimmune Disorders
Figure 10. Cardiovascular Diseases
Figure 11. Antibody Drugs Report Years Considered
Figure 12. Global Antibody Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Antibody Drugs Sales 2015-2026 (mg)
Figure 14. Global Antibody Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Antibody Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Antibody Drugs Sales Market Share by Region in 2019
Figure 17. Global Antibody Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Antibody Drugs Revenue Market Share by Region in 2019
Figure 19. Global Antibody Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Antibody Drugs Revenue in 2019
Figure 21. Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Antibody Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Antibody Drugs Sales Market Share by Type in 2019
Figure 24. Global Antibody Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Antibody Drugs Revenue Market Share by Type in 2019
Figure 26. Global Antibody Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Antibody Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Antibody Drugs Sales Market Share by Application in 2019
Figure 29. Global Antibody Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Antibody Drugs Revenue Market Share by Application in 2019
Figure 31. North America Antibody Drugs Sales Growth Rate 2015-2020 (mg)
Figure 32. North America Antibody Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Antibody Drugs Sales Market Share by Country in 2019
Figure 34. North America Antibody Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 36. U.S. Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 38. Canada Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Antibody Drugs Market Share by Type in 2019
Figure 40. North America Antibody Drugs Market Share by Application in 2019
Figure 41. Europe Antibody Drugs Sales Growth Rate 2015-2020 (mg)
Figure 42. Europe Antibody Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Antibody Drugs Sales Market Share by Country in 2019
Figure 44. Europe Antibody Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 46. Germany Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 48. France Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 50. U.K. Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 52. Italy Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 54. Russia Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Antibody Drugs Market Share by Type in 2019
Figure 56. Europe Antibody Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Antibody Drugs Sales Growth Rate 2015-2020 (mg)
Figure 58. Asia Pacific Antibody Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Antibody Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Antibody Drugs Revenue Market Share by Region in 2019
Figure 61. China Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 62. China Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 64. Japan Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 66. South Korea Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 68. India Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 70. Australia Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 72. Taiwan Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 74. Indonesia Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 76. Thailand Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 78. Malaysia Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 80. Philippines Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 82. Vietnam Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Antibody Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Antibody Drugs Market Share by Application in 2019
Figure 85. Latin America Antibody Drugs Sales Growth Rate 2015-2020 (mg)
Figure 86. Latin America Antibody Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Antibody Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Antibody Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 90. Mexico Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 92. Brazil Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 94. Argentina Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Antibody Drugs Market Share by Type in 2019
Figure 96. Latin America Antibody Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Antibody Drugs Sales Growth Rate 2015-2020 (mg)
Figure 98. Middle East and Africa Antibody Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Antibody Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Antibody Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 102. Turkey Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 104. Saudi Arabia Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Antibody Drugs Sales Growth Rate (2015-2020) (mg)
Figure 106. U.A.E Antibody Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Antibody Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Antibody Drugs Market Share by Application in 2019
Figure 109. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. North America Antibody Drugs Sales Growth Rate Forecast (2021-2026) (mg)
Figure 121. North America Antibody Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Europe Antibody Drugs Sales Growth Rate Forecast (2021-2026) (mg)
Figure 123. Europe Antibody Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Asia Pacific Antibody Drugs Sales Growth Rate Forecast (2021-2026) (mg)
Figure 125. Asia Pacific Antibody Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Latin America Antibody Drugs Sales Growth Rate Forecast (2021-2026) (mg)
Figure 127. Latin America Antibody Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Middle East and Africa Antibody Drugs Sales Growth Rate Forecast (2021-2026) (mg)
Figure 129. Middle East and Africa Antibody Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Porter's Five Forces Analysis
Figure 131. Channels of Distribution
Figure 132. Distributors Profiles
Figure 133. Bottom-up and Top-down Approaches for This Report
Figure 134. Data Triangulation
Figure 135. Key Executives Interviewed
